Skip to main content
SpringerLink
Log in

Current Surgical Management of Primary Cutaneous Melanoma

  • Chapter
  • First Online:
Book cover Melanoma

  • 1638 Accesses

Abstract

The surgical management of melanoma has dramatically changed over the last few decades. Through the development and conduction of well-designed prospective, randomized trials, we have been able to refine the way that we surgically manage patients with melanoma. Indeed, many important issues have been addressed through such trials: the proper surgical margins for the primary melanoma, utility of the elective lymph node dissection, and the role for selective lymphadenectomy, to name a few. In this review, we will provide an overview of the current literature and offer practice guidelines for the surgical management of the primary melanoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CLND:

Complete lymph node dissection

ELND:

Elective lymph node dissection

NCCN:

National Comprehensive Care Network

PET:

Positron emission tomography

SLN:

Sentinel lymph node(s)

SLNB:

Sentinel lymph node biopsy

References

  1. Urteaga OB, Pack GT. On the antiquity of melanoma. Cancer. 1967;19:607–10.

    Article  Google Scholar 

  2. Home Sir Everhard. Observations on cancer. London. 48 (1805).

    Google Scholar 

  3. Laennec RTH. Sur les melanoses. Bull Fac Med Paris. 1812;1:2.

    Google Scholar 

  4. Norris W. Case of fungoid disease. Edinburgh Med Surg J. 1820;16:562.

    Google Scholar 

  5. Norris W. Eight cases of melanosis with pathological and therapeutical remarks on that disease. London: Longman, Brown, Green, Longman and Roberts; 1857.

    Google Scholar 

  6. Parrish I. Case of melanosis. Am J Med Sci. 1837;20:266.

    Google Scholar 

  7. Cooper S. The first lines of the theory and practice of surgery. London: Longman; 1840.

    Google Scholar 

  8. Pemberton O. Observations on the history, pathology and treatment of cancerous diseases. London: Churchill J; 1858.

    Google Scholar 

  9. Snow H. Melanotic cancerous disease. Lancet. 1892;2:872–4.

    Google Scholar 

  10. Eve F. Lecture on melanoma. Practitioner. 1903;70:165.

    Google Scholar 

  11. Handley WS. The pathology of melanotic growths in relation to their operative treatment (II). Lancet. 1907;1:996–1001.

    Google Scholar 

  12. Clark WH Jr, From L, Bernardino EA, Mihm MC Jr. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969;29:705–27.

    PubMed  Google Scholar 

  13. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172:902–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Breslow A, Cascinelli N, van der Esch EP, Morabito A. Stage I melanoma of the limbs: assessment of prognosis by levels of invasion and maximum thickness. Tumori. 1978;64:273–8.

    Article  CAS  PubMed  Google Scholar 

  15. Fee HJ, Robinson DS, Sample WF, et al. The determination of lymph shed by colloidal gold scanning patients with malignant melanoma: a preliminary study. Surgery. 1987;84:626–32.

    Google Scholar 

  16. Morton D, Cagle L, Wong J, et al. Intraoperative lymphatic mapping and selective lymphadenectomy: technical details of a new procedure for clinical stage I melanoma. Presented at the Annual Meeting of the Society of Surgical Oncology; Washington, DC. 1990.

    Google Scholar 

  17. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.

    Article  CAS  PubMed  Google Scholar 

  18. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355(13):1307–17.

    Article  CAS  PubMed  Google Scholar 

  19. Salopek TG, Slade J, Marghoob AA, et al. Management of cutaneous malignant melanoma by dermatologists of the American Academy of Dermatology. I. Survey of biopsy practices of pigmented lesions suspected as melanoma. J Am Acad Dermatol. 1995;33:441–50.

    Article  CAS  PubMed  Google Scholar 

  20. Kanzler MH, Mraz-Gernhard S. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview. J Am Acad Dermatol. 2001;54:260–76.

    Article  Google Scholar 

  21. Thomas L, Tranchard P, Berard F, Secchi T, Colin C, Moulin G. Semiological value of ABCD criteria in the diagnosis of cutaneous pigmented tumors. Dermatology. 1998;197:11–7.

    Article  CAS  PubMed  Google Scholar 

  22. Weinstock MA. Early detection of melanoma. JAMA. 2000;284:886–9.

    Article  CAS  PubMed  Google Scholar 

  23. Nachbar F, Soltz W, Merkle T, et al. The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol. 1994;30:551–9.

    Article  CAS  PubMed  Google Scholar 

  24. McGovern TW, Litaker MS. Clinical predictors of malignant pigmented lesions. A comparison of the Glasgow seven-point checklist and the American Cancer Society’s ABCD of pigmented lesions. J Dermatol Surg Oncol. 1992;18:22–6.

    Article  CAS  PubMed  Google Scholar 

  25. Argenziano G, Soyer H. Dermoscopy of pigmented skin lesions—a valuable toll for early diagnosis of melanoma. Lancet Oncol. 2001;2:443–9.

    Article  CAS  PubMed  Google Scholar 

  26. Argenziano G, Fabbrocini G, Carli P, DeGiogi V, Sammarco E, Delfino M. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol. 1998;134:1563–70.

    Article  CAS  PubMed  Google Scholar 

  27. Breslow A. Prognostic factors in the treatment of cutaneous melanoma. J Cutan Pathol. 1979;6:208–12.

    Article  CAS  PubMed  Google Scholar 

  28. Clark WH Jr, Elder DE, Guerry DT, et al. Model predicting survival instage I melanoma based on tumor progression. J Natl Cancer Inst. 1989;81:1893–904.

    Article  PubMed  Google Scholar 

  29. Farmer ER. Why a skin biopsy? Arch Dermatol. 2000;136:779–80.

    Article  CAS  PubMed  Google Scholar 

  30. Herlyn M, Ferrone S, Ronai Z, Finerty J, Pelroy R, Mohla S. Melanoma biology and progression. Cancer Res. 2001;61:4642–3.

    PubMed  CAS  Google Scholar 

  31. Johnson TM, Sondak VK. Melanoma margins: the importance and need for more evidence-based trials. N Engl J Med. 2004;350:757–66.

    Article  Google Scholar 

  32. Landthaler M, Braun-Falco O, Leitl A, Konz B, Holzel D. Excisional biopsy as the first therapeutic procedure versus primary wide local excision of malignant melanoma. Cancer. 1989;64:1612–6.

    Article  CAS  PubMed  Google Scholar 

  33. Levi F, Randimbison L, LaVecchia C, Te VC, Frandeschi S. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland. Int J Cancer. 1998;78:315–9.

    Article  CAS  PubMed  Google Scholar 

  34. Macy-Roberts E, Ackerman AB. A critique of techniques for biopsy of clinically suspected malignant melanomas. Am J Dermatopathol. 1982;4:391–8.

    Article  CAS  PubMed  Google Scholar 

  35. Riker AI, Glass F, Perez I, Cruse CW, Messina J, Sondak VK. Cutaneous melanoma: methods of biopsy and definitive surgical excision. Dermatol Ther. 2005;18:387–93.

    Article  PubMed  Google Scholar 

  36. Roses D. Biopsy technique for suspected melanoma. Pigment Cell. 1985;7:8–17.

    Google Scholar 

  37. Amin MB, Edge S, Greene F, et al., editors. AJCC cancer staging manual. 8th ed. New York: Springer; 2016. p. 563–85.

    Google Scholar 

  38. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer. 2001;88:3635–48.

    Google Scholar 

  39. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients. Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622–34.

    Article  CAS  PubMed  Google Scholar 

  40. Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2-cm surgical margins for intermediate thickness melanomas (1–4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg. 1993;218(3):262–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Balch CM, Soong SJ, Ross MI, et al. Long term results of a prospective trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1–4 mm melanomas. Ann Surg Oncol. 2001;8:101–8.

    PubMed  CAS  Google Scholar 

  42. Gillgren P, Drzewiecki KT, Niin M, et al. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2mm: a randomised, multicenter trial. Lancet. 2011;378:1635–42.

    Article  PubMed  Google Scholar 

  43. Khayat D, Rixe O, Martin G, et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1 mm thick). Cancer. 2003;97:1941–6.

    Article  PubMed  Google Scholar 

  44. Cohn-Cedermark G, Rutqvist LE, Andersson R, et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2 cm versus 5 cm resection margins for patients with cutaneous melanoma with a thickness of 0.8 to 2.0 mm. Cancer. 2000;89:1495–501.

    Article  CAS  PubMed  Google Scholar 

  45. Tanabe KK, Reintgen DS, Balch CM. Local recurrences and their management. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, editors. Cutaneous melanoma. 4th ed. St. Louis, MI: Quality Medical Publishing; 2003. p. 263–73.

    Google Scholar 

  46. Veronesi U, Cascinelli N, Adamus J, et al. Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N Engl J Med. 1988;322:1159–62.

    Article  Google Scholar 

  47. Santinarni M, Maurici A, Patuzzo R, et al. Impact of clinical trials on the treatment of melanoma. Surg Oncol Clin N Am. 2001;10:935–47.

    Article  Google Scholar 

  48. Hudson LE, Maithel SK, Carlson GW, et al. 1 or 2 cm margins of excision for T2 melanomas: do they impact recurrence or survival? Ann Surg Oncol. 2013;20:346–51.

    Article  PubMed  Google Scholar 

  49. Doepker MP, Thompson ZJ, Fisher KJ, Yamamoto M, Nethers KW, Harb JN, Applebaum MA, Gonzalez RJ, Sarnaik AA, Messina JL, et al. Is a wider margin (2cm vs. 1 cm) for a 1.01-2.0 mm melanoma necessary? Ann Surg Oncol. 2016;23(7):2336–42.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Thomas JM, Newton-Bishop J, A’Hern R, et al. Excision margins in high-risk malignant melanoma. N Engl J Med. 2004;350:757–66.

    Article  CAS  PubMed  Google Scholar 

  51. Heaton KM, Sussman JJ, Gershenwald JE, et al. Surgical margins and prognostic factors in patients with thick (>4 mm) primary melanoma. Ann Surg Oncol. 1998;5:322–8.

    Article  CAS  PubMed  Google Scholar 

  52. Kenady DE, Brown BW, McBride CM. Excision of underlying fascia with a primary malignant melanoma: effect on recurrence and survival rates. Surgery. 1982;92(4):615–8.

    PubMed  CAS  Google Scholar 

  53. Sondergaard K, Schou G. Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I. A multivariate regression analysis. Virchows Arch A Pathol Anat Histopathol. 1985;408(2-3):249–58.

    Article  CAS  PubMed  Google Scholar 

  54. Corsten M, Johnson-Obaseki S. Sentinal lymph node biopsy in head and neck melanoma: a review. J Patient-Centered Res Rev. 2014;1(1):27–32.

    Article  Google Scholar 

  55. Cruse CW, Wells KE, Reintgen DS. Treatment of the primary in malignant melanoma of the skin. Ann Plast Surg. 1992;28:22–5.

    Article  CAS  PubMed  Google Scholar 

  56. Cochran AM, Buchanan PJ, Bueno RA Jr, et al. Subungual melanoma: a review of current treatment. Plast Reconstr Surg. 2014;134(2):259–73.

    Article  CAS  PubMed  Google Scholar 

  57. Haddock NT, Wilson SC, Shapiro RL, et al. Wide local en bloc excision of subungual melanoma in situ. Ann Plast Surg. 2014;73(6):640–4.

    Article  CAS  PubMed  Google Scholar 

  58. Nakamura Y, Ohara K, Kishi A, et al. Effects of non-amputative wide local excision on the local control and prognosis of in situ and invasive subungual melanoma. J Dermatol. 2015;42(9):861–6.

    Article  PubMed  Google Scholar 

  59. Anda-Juarez MC, Martinez-Velasco MA, Fonte-Avalos V, et al. Conservative surgical management of in situ subungual melanoma: long-term follow-up. An Bras Dermatol. 2016;91(6):846–8.

    Article  PubMed  PubMed Central  Google Scholar 

  60. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Melanoma, version 1.2017. National Comprehensive Cancer Network, Fort Washington, PA. 2016. www.NCCN.org

Download references

Author information

Authors and Affiliations

  1. Section of Surgical Oncology, Department of Surgery, School of Medicine, Louisiana State University, New Orleans, LA, USA

    Adam I. Riker M.D., F.A.C.S., Marco Antonio Rajo M.D. & Jonathan S. Lam M.D.

  2. Department of Family Medicine, Health Science Center, Louisiana State University, New Orleans, LA, USA

    Stephen L. Lambert M.D.

Authors
  1. Adam I. Riker M.D., F.A.C.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marco Antonio Rajo M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephen L. Lambert M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jonathan S. Lam M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam I. Riker M.D., F.A.C.S. .

Editor information

Editors and Affiliations

  1. Louisiana State University, New Orleans, Louisiana, USA

    Adam I. Riker

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Riker, A.I., Rajo, M.A., Lambert, S.L., Lam, J.S. (2018). Current Surgical Management of Primary Cutaneous Melanoma. In: Riker, A. (eds) Melanoma. Springer, Cham. https://doi.org/10.1007/978-3-319-78310-9_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-78310-9_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-78309-3

  • Online ISBN: 978-3-319-78310-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation